Because even pharmacological short-term inhibition of glycolysis- and OGT-activity influenced IFNγ production and STAT1 phosphorylation, we propose that this mechanism equips Th1 cells to adapt dynamically to their environment; this could have important consequences for anti-tumor immunity. This evidence concerns the gene STAT1 and neoplasm.